Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
10 hedge funds and large institutions have $229K invested in Histogen Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 15 closing their positions.
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
55% less funds holding
Funds holding: 22 → 10 (-12)
77% less capital invested
Capital invested by funds: $988K → $229K (-$759K)
80% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Prudential Financial
Newark,
New Jersey
|
+$46.7K |
| 2 |
HF
HRT Financial
New York
|
+$40.8K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$37.9K |
| 4 |
JP Morgan Chase
New York
|
+$19.4K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$4 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$292K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$126K |
| 3 |
State Street
Boston,
Massachusetts
|
-$43K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$39K |
| 5 |
Millennium Management
New York
|
-$24K |
HSTO Hedge Fund Activity: Q2 2022 in Review
10 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q2 2022, worth a combined $229K — down 77% from $988K a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of HSTO and 3 opened new positions — a net loss of 12 holders — while 3 trimmed existing stakes and 2 added.
The largest buyer was Prudential Financial, opening a new position worth an estimated $46.7K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $292K sold.
- 10 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q2 2022, down from 22 in Q1 2022.
- Funds reported $229K of Histogen Inc. Common Stock stock for Q2 2022, down 77% quarter-over-quarter.
- 3 funds opened new Histogen Inc. Common Stock positions in Q2 2022 and 15 closed out, a net change of -12 holders.
- The largest Histogen Inc. Common Stock buyer in Q2 2022 was Prudential Financial, an estimated $46.7K added.
- The largest Histogen Inc. Common Stock seller in Q2 2022 was Renaissance Technologies, an estimated $292K sold.
Based on aggregated 13F filings for Q2 2022.